Effect of a femoral arteriovenous fistula on lower extremity venous hemodynamics after femorocaval reconstruction  by Menawat, Sunil S. et al.
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Purpose: To study the hemodynamic effects of  an arteriovenous fistula (AVF) used as an 
adjunct to venous reconstructions and to determine the optimal size for such a fistula. 
Methods: A model of  limb circulation with an AVF (in vitro system) was constructed with 
silicon elastic tubes and 40% glycerin solution as the fluid medium. Pulsatile arterial flow 
and venous return was maintained with a roller pump and a centrifugal assist device. Flows 
and pressures were measured for three different fistula diameters (3, 4, and 5 mm). A 
canine model of  venous hypertension with outflow obstruction was constructed in 15 adult 
mongrel dogs. After 7 to 13 days an externally supported 8-mm expanded polytetrafluo- 
roethylene f morocaval graft was implanted with a distal AVF (3 ram, n = 5; 4 mm, n = 5; 
5 ram, n = 5). Arterial and venous flows and venous pressures were measured proximal and 
distal to the fistula before and after exercise. 
Results: In  the in vitro system, flows through the venous graft increased with increasing 
fistula size, but venous return decreased progressively, increasing the distal venous 
pressure. In the canine model, flow in the venous graft increased with each AVF (p < 0.01). 
Only the 3-mm AVF resulted in decreased istal femoral vein pressure (p < 0.01), 
orthograde flow, and improved venous return with exercise. 
Conelusion:AVFs increased flow through the femorocaval grafts, yet they impeded venous 
return. The ideal AVF-to-graft ratio used in our study was 0.375, because it increased graft 
flow, permitted forward flow in the femoral vein while reducing pressure, and improved 
venous return with exercise. (J Vasc Surg 1996;24:793-9.) 
Venous thrombectomy performed for iliofemoral 
venous thrombosis or bypass procedures performed 
for venous occlusion are surgical options that are 
used to treat patients for acute or chronic venous 
occlusive disease. Patency rates after venous recon- 
structions, however, have been found to be inferior 
to those obtained after arterial reconstructions. 1-7An 
arteriovenous fistula (AVF) placed distal to venous 
reconstructions in an attempt to improve patency 
was first suggested by Kunlin et al. in 1953, and it 
has been used with success in several series published 
in the literature. 3 s,8-14 Our clinical experience with 
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prosthetic femorocaval grafts (FCGs) implanted with 
a femoral AVF has also been reported)  ,1~,16 Venous 
hypertension, however, is observed in some patients 
after placement o f  a distal AVF, and. at present the 
optimal size and location of  the fistula is 
controversial. 17-19 
The goal o f  our experiments was to evaluate the 
acute hemodynamic changes that occur after place- 
ment o f  an AVF. An in vitro model of  normal limb 
circulation and a canine model o f  venous hyperten- 
sion, treated with FCGs, were used. 
METHODS 
In  vitro model .  An in vitro model limb circula- 
tion with an AVF was constructed with 8 -mm silicon 
elastic tubing (Fig. 1). A 40% glycerin solution was 
used as the fluid medium.2° Pulsatilc arterial flow was 
maintained with a roller pump, and venous return was 
sustained with a centrifugal assist device. Mean arte- 
rial pressure in the model was maintained at 68 to 70 
mm Hg,  and the venous pressure when the AVF was 
clamped was maintained at 8 to 10 mm Hg. Venous 
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Fig. 1. In vitro model of limb circulation with AVF. 
Centrifugal 
assist device 
flow and pressures were measured for three different 
fistula diameters (3, 4, and 5 ram). A valve in the distal 
venous segment prevented reversal of flow. Each 
measurement was repeated 10 times, and mean 
values + SEM were used. 
Canine model. A model of chronic venous hy- 
pertension was created, modified from the method 
described by Lalka et al. 21 in 15 male mongrel dogs, 
each weighing 20 to 25 pounds. The femoral vein was 
ligated at the inguinal igament. All tributaries of the 
femoral vein were also ligated for a length of 5 cm 
from the inguinal igament (Fig. 2). All dogs received 
325 mg of aspirin 2 days before the ligation and every 
day until completion of the study. After 7 to 13 days, 
flow and pressure measurements were obtained to 
confirm venous hypertension. At this time, an 8-mm 
externally supported expanded polytetrafluoroethyl- 
ene (ePTFE) FCG was implanted. A femoral AVF 
using an ePTFE graft of 3 ram, 4 mm, or 5 mm in 
diameter was also performed, at 1 to 2 cm distal to the 
anastomosis (Fig. 3), and the hemodynamic measure- 
ments were obtained. The fistula was placed at 90 
degrees to the long axis of the vessels. The animals 
received intravenous gentamicin 80 rag, intravenous 
cefazolin sodium 1 gm, and intramuscular penicillin G 
benzathine 1.2 million units before bypass surgery. 
Intravenous pentobarbital was used for general anes- 
thesia. 
The dogs were randomly assigned to one of three 
groups. Group I (five dogs) had a 3-ram fistula, group 
2 (five dogs) had a 4-ram fistula, and group 3 (five 
dogs) had a 5-mm fistula. The fistula-to-graft diam- 
eter ratio swere 0.375, 0.5, and 0.625 for groups 1, 2 
and 3, respectively. Arterial and venous flows and 
venous pressures were measured proximal and distal 
to the fistula. Exercise was simulated by electrical 
stimulation to tetany of the leg musculature for 20 
seconds. After stimulation an immediate flow and 
pressure reading was taken. Subsequently, 10 more 
similar eadings were taken 30 seconds apart, and the 
dogs were allowed to recover. All flow readings were 
taken using an ultrasound flow probe flowmeter from 
Transonic Systems, Inc. Two weeks from the bypass 
surgery, the groin was reexplored to examine for 
patency and to obtain the flow and pressure measure- 
meri ts .  
Data analysis was performed with Student's paired 
t test when comparing within a group and with the 
unpaired t test when comparisons were performed 
between groups. Significance was defined as a p value 
less than 0.05. The SEM was calculated for a 95% 
confidence interval. 
RESULTS 
In vitro model. The flow pattern and pressure in 
the system were dependent on the size of the AVF. 
Flow through the proximal vein increased with in- 
creasing fistula size, whereas the inflow from the distal 
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Fig. 2. Model of venous outflow obstruction i hind limb 
of dog with ligation of femoral vein and profmada femoris. 
vein decreased (Table I). The pressure in the distal 
vein increased with fistula size (Fig. 4 and Table I). 
The 5-mm fistula resulted in no inflow from the distal 
vein. A valve prevented reversal of flow in the in vitro 
system. 
Canine model. After ligation of the femoral vein 
and its tributaries, there was an acutc rise in the 
femoral vein pressure, from a mean of 8.2 mm Hg 
(range, 7 to I1 mm Hg) to 91 mm Hg (range, 50 to 
123 mm Hg). One to two weeks later, at the time of 
the femorocaval venous bypass procedure, the femo- 
ral vein pressure had decreased to a mean of 31.5 mm 
Hg (range, 21 to 39 mm Hg), but remained higher 
than baseline (p < 0.01). To confirm venous occlu- 
sion, the flow in the femoral vein was measured before 
reconstruction a d was found to be zero in all dogs. 
Mean changes in pressure with placement of a 
" / / ~7~;~ Flow Meter 
Fig. 3. Femorocaval bypass graft with fcmoral AVF. Flow 
probes were placed as shown. 
FCG and an AVF are shown in Table II. The fistula- 
to - graft ratio of 0.375 (group 1 ) resulted in a signifi -
cant decrease in thc prcssurc in the femoral vein 
(p < 0.02), whereas the larger ratios resulted in no 
significant decrease in the prcssurc and even increased 
the distal femoral pressures in several dogs (Fig. 5). 
M1 AVFs resulted in increased flow through the 
FCG (Table III). The flow was grcatcst with a 5-mm 
fstula and less with smaller fistulas. An AVF increased 
flow in the proximal artery and decreased flow in the 
distal artery in all cases. The flow in the femoral vein 
was orthograde in four of five dogs with a 3-mm 
fistula, but was rcvcrscd in all dogs with 4-ram or 
5-ram fistulas (Fig. 6). 
In the period after electrical stimulation, marked 
increase in venous outflow was measured from the 
distal femoral vein for a 3-mm fistula from 7 ml/min 
to 67 ml/min (p < 0.05; Table III). The flow in- 
creased in the distal artery yet decreased in the 
proximal artery, which is consistent with decreased 
flow through the AVF during exercise. The increased 
venous outflow from the distal femoral vein did not 
return completely to baseline during the 5 minutes 
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Fig. 4. In vitro model. Change in mean venous pressure after insertion ofAVF. SEM is less than 
0.7 for proximal artery pressure and less than 0.25 for proximal and distal venous pressure values. 
Table I. Hemodynamics of the in vitro system 
Flow from distal vein 
Fistula (mm) (+ SEM) (ml/min) 
Distal venous pressure 
%SEM) (mm Hg) 
Proximal venous pressure 
\ (+SEM),(mm Hg) 
none (basefine) 980 + 3 10 + 0.7 - -  
3 590 + 2* 20 + 0* 14 + 0 
4 230 +2"  28 + 0* 20 +0 
5 0+0"  45+0*  22+0 
*p < 0.01. 
Table II. Femoral venous pressure before and after femorocaval bypass with AVF and after exercise 
Immediately 5 minutes 
Preoperative Postoperative after exercise after recovery 
Fistula (mm) (+SEM) (mm Hg) (+SEM) (mm Hg) (+SEM) (mm Hg) (+SEM) (mm Hg) 
3 33 + 4.7 15.6 + 2.1" 16.8 + 1.61" 15 + 2.81" 
4 30 + 5.0 30.4 + 8.9 t 25.2 + 6.4 t 30.8 + 6.91" 
5 32 + 4.0 43.6 + 20.81" 42.2 + 18.41" 41.6 + 22.81" 
*p < 0.02. 
1"Not significant. 
while measurements were done. Pressure changes in 
the femoral vein immediately after exercise were not 
significant in any of the groups (Table II). 
On reexploration at 2 weeks, only three grafts 
were patent, two with 5-mm fistulas (group 3) and 
one with a 4-ram fistula (group 2). Eight AVFs were 
patent at 2 weeks, four in group 3 and two each in 
groups 1 and 2. The flow readings in the patent grafts 
were negligible (mean, 10 ml/min). All three patent 
grafts were filled with large amount of thrombus. 
DISCUSSION 
An AVF results in a preferential low-resistance 
path for blood flow from the arterial to the venous 
system. The hemodynamic changes brought about by 
the fistula are mainly dependent on the diameter of 
the fistula. Even a small fistula results in increased flow 
in the proximal artery, and the proximal vein and flow 
in the distal artery is usually decreased. Flow in the 
distal vein may be orthograde or retrograde. A com- 
petent valve can prevent retrograde flow in the distal 
vein, but increased pressure with time may result in 
annular dilatation, valvular incompetence, and retro- 
grade flow. 22 Retrograde flow can also be prevented if 
resistance through the proximal vein or FCG is low 
and is able to accommodate the increased flow caused 
by the fistula. So when designing an AVF, it is 
important o consider fistula size and changes in 
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Fig. 5. Canine model. Distal femoral venous pressure after femorocaval bypass procedure and 
AVF. 
Table II I . Flow rate after femorocaval bypass and AVF, before and after electrical 
stimulation (exercise) 
Inflow artery Outflow artery Femoral vein Femorocaval graft 
Fistula ( ram)  (+_SEM)Onl~min) (+_SEM) (ml/min) (+-SEM) (ml/min) (+_SEM) (ml/min) 
/ 
clamped 132+ 17 \ 147+_ 16 68.8+ 16 85.2+ 14 
Before After Before After Before After Before After 
3 495+57*  397+ 114 t 99+21"  140+33 t 7+28*  67+80§  242+88*  254+107"  
4 533 + 51" 373 _+ 89 t 89 + 20* 97 + 40 t -93 + 21":~ -71 + 54tJ; 224 + 62* 157 + 72* 
5 754+133"  669-+325 t 71+33"  80+46 t -136 + 46":~ -133 + 103tz ~ 399+112"  351+237"  
*p < 0.01. 
tNot significant. 
:~Reversed flow. 
§p < 0.05. 
arterial, and, more importantly, venous hemody- 
namics. 
The use of an AVF was first suggested by Kunlin et 
al. 8 in 1953 to assist the patency of a venous graft. 
Bryant et al. 23 in an experimental study, first used 
AVFs to maintain the patency of prosthetic grafts 
placed in the venous ystem. Experimental studies in 
our laboratories 24-26 and in others, 17'18 and clinical 
s tud ies  1-7'9~a7 have reported on the use of  AVF as an 
adjunct o improve the patency of venous grafts. 
Whereas previous experimental studies have fo- 
cused on the utility of AVF to maintain patency, our 
study investigated acute hemodynamic alterations 
using ePTFE prostheses of different sizes for AVF in 
a model of venous hypertension. The fistula was 
placed at 90 degrees to the long axis of  the artery and 
vein to minimize its length, which allowed for mini- 
mal resistance at each diameter. 
Main factors that influence flow rate through a 
venous bypass graft are its diameter and length. It is by 
increasing the flow rate through the bypass graft that 
AVF has its beneficial effect. Previous tudies in our 
laboratory showed that increasing flow resulted in 
decreased platelet and decreased fibrin deposition in 
prosthetic grafts placed in the venous ystem. 24 It has 
also been demonstrated that higher flow is associated 
with improved patency after venous reconstruc- 
tions.l-7,9-17 
Several authors have suggested the use of an AVF 
only as a temporary adjunct to venous reconstruc- 
tions. 3'6'9"14'27 Others reported graft occlusion after 
takedown of the AVF. 3,4'24 It would be ideal if the 
benefit of AVF could be maximized while any harmful 
consequences were controlled. 
Our in vitro model confirmed our hypothesis that 
although alarger fistula results in increased flow in the 
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Fig. 6. Canine model. Mean arterial and venous flow after femorocaval bypass procedure and 
AVF. 
proximal vein, it also increases significantly the distal 
venous pressure. The larger the fistula, the less is the 
venous outflow from the extremity. Using a 5-mm 
AVF in the in vitro model, venous return was com- 
pletely interrupted. 
The canine model demonstrated that after a by- 
pass procedure isperformed on an occluded iliofemo- 
ral venous ystem the venous pressure in the limb was 
dependent on the size of the fistula. With a fistula-to- 
graft ratio of 0.375, distal femoral venous pressure 
was reduced and was near normal. It did not decrease 
compared with preoperative alues, with a fistula-to- 
graft ratio of 0.5 or higher. 
Exercise had beneficial effect on the limb hemo- 
dynamics. After electrical stimulation, a significant 
increase in venous return was noted in group I (fistula 
diameter , 3 mm), from 7 ml/min to 67 ml/min. No 
significant increase in distal venous return could be 
demonstrated, however, in groups 2 and 3 with 
exercise. There was increase in flow in the distal artery; 
however, it was not statistically significant. There was 
decrease in proximal artery flow. The mechanism of 
this change in the flow pattern is not clear, but it 
appears to be a result of decreased flow through the 
AVF during exercise. We observed high venous pres- 
sures in the limb during muscle contractions. We also 
hypothesize that venous compliance in the limb 
decreases during and after exercise, resulting in higher 
venous return. These changes in the local hemody- 
namics result in decreased flow through the AVF. 
However, these changes are not observed in the 
presence of a large AVF because the higher flow 
through fistula overcomes these compliance changes. 
We were unable to evaluate the hemodynamic 
changes at 2 weeks in this model because of the high 
occlusion rate of our grafts. Autopsy evaluation re- 
vealed thrombus in the vein, in most cases extending 
from the fistula to the inguinal igament where the 
graft had bccn externally compressed between scar 
and the inguinal ligament. It is apparent from this 
study that the model is not adequate to evaluate 
long-term results in venous reconstruction. 
We conclude that flow can be increased in a 
venous graft or thrombectomized vein with the use 
of an AVF. The price that must be paid, however, 
is the increase in distal venous pressure and the 
potential decrease of venous outflow from the im- 
paired extremity. If  venous outflow obstruction is 
treated with reconstruction, a fistula-to-graft ratio of 
0.375 will increase flow through the graft and still 
allow orthograde flow in the distal vein with de- 
creased pressures compared with preoperative alues. 
Exercise promotes orthograde flow in the presence 
of such an AVF. 
Our current recommendations on the construc- 
tion of an AVF at the groin in patients who undergo 
femorofcmoral orprosthetic FCG procedures are the 
following. For a 10-mm graft, a 3-mm to 4-ram fistula 
should be used to maintain afavorable graft-to-fistula 
ratio. If  pressure measurements in the vein show 
increased values compared with the pressures from 
before reconstruction, the fistula should be further 
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nar rowed to decrease flow. Similarly, i f  an intraopera-  
tive duplex scan conf i rms f low reversal in the vein 
distal to the fistula, the size o f  the fistula shou ld  be 
decreased. I f  possible,  fistulas in our  pat ients are 
mainta ined  whi le the bypass grafts are patent  to 
prov ide the maximal  benefit .  
The authors would like to acknowledge Marcia Sim- 
onson for editorial assistance and Alice McKinney for 
assistance with illustrations. 
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